Olympus Corporation of the Americas

What Olympus Corporation of the Americas does

Olympus Corporation of the Americas is the regional headquarters for Olympus Corporation (Japan) across North and South America, operating as a wholly-owned subsidiary headquartered in Center Valley, Pennsylvania with 5,300+ employees in 13+ offices spanning the United States, Canada, Mexico, Brazil, Chile, and Puerto Rico. The company is a MedTech platform specializing in minimally invasive medical technology across four primary specialty verticals — Gastroenterology, Urology, Pulmonology, and ENT — with secondary exposure to General Surgery, Ambulatory Surgical Centers, federal healthcare facilities, and infection prevention. Core products include the EVIS X1 endoscopy system with proprietary imaging modes (TXI, RDI, BAI-MAC, NBI), the VISERA ELITE III surgical imaging platform co-developed with Sony Olympus Medical (SOMED), the POWERSEAL advanced bipolar surgical energy portfolio, single-use bronchoscopes and rhinolaryngoscopes (H-SteriScope and E-SteriScope), and the Olympus EBUS, Hybrid Bronchoscopy, and iTind solutions. The portfolio is underpinned by digital workflow software (OLYSENSE, Olympus Knowledge Exchange), reprocessing consumables, the Olympus Continuum educational platform with a Surgical Training & Innovation Center in Brooklyn Park MN, and Olympus Financing.

The business model combines hardware sales (capital equipment and consumables), recurring service and repair (National Service Centers East/West, MyOlympus Service portal), leasing and financing, professional training and education, reprocessing products, and corporate venture returns (Olympus Innovation Ventures Fund II, $150M). Go-to-market relies on a large field-based specialty sales force (Respiratory, EndoTherapy, URO/GYN territory managers), inside sales and customer care, distribution partnerships (First Nation Group for federal facilities, EndoRobotics for robotics, Latin America regional subsidiaries), and event presence at major medical conferences. Pricing is quote-based and not publicly disclosed; service agreements are multi-year. In 2025-2026 the company has executed a notable cadence of product launches, FDA clearances (pediatric H-SteriScope, POWERSEAL Open Jaw), partnerships (Canon for Aplio i800 EUS, EndoRobotics, First Nation Group), an acquisition (BioProtect for prostate cancer), and leadership restructuring under incoming Regional President Richard Reynolds to streamline across five regions with explicit AI and robotics integration focus.

Name

Olympus Corporation of the Americas

Legal name

Olympus Corporation of the Americas

Website

https://olympusamerica.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Olympus Corporation of the Americas is the regional subsidiary of Olympus Corporation (Japan), selling minimally invasive medical technology platforms — endoscopes, surgical imaging, bipolar energy, and single-use devices — across gastroenterology, urology, pulmonology, and ENT specialties to hospitals, ASCs, and physicians throughout North and South America.

Ownership category

akta.pro rank

Product category

Medical Devices & Surgical Equipment

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)

akta.pro secondary industry

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

• Minimally invasive medical devices
• Surgical imaging systems
• Endoscopy equipment
• Surgical energy devices
• Medical device manufacturing

Headquarters

HQ city

Center Valley

HQ country

United States

HQ region

North America

Offices14 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Medical Device Hardware Sales: Primary revenue from sale of medical and surgical hardware including endoscopes (EVIS X1, VISERA ELITE III, VISERA S), surgical energy devices (POWERSEAL, Thunderbeat), single-use devices (H-SteriScope bronchoscopes, E-SteriScope rhinolaryngoscopes), and urological/respiratory equipment. Federal healthcare facility distribution agreement with First Nation Group expands hardware channel reach.
2. Service, Repair, and Maintenance: Recurring revenue from service agreements, repair services, loaner programs, and Certified Pre-owned equipment sales. Operated through National Service Centers East (Bartlett, TN) and West (San Jose, CA) and Repair Technicians across geographies. MyOlympus Service online portal supports customer service operations.
3. Professional Education and Training: Revenue and value-add through Olympus Continuum™ educational programs, Olympus Surgical Training & Innovation Center in Brooklyn Park, MN, Advanced Endoscopy Fellows Courses, and HCP Consulting LMS. Includes physician training across multiple specialties.
4. Financial Services and Leasing: Leasing and financing programs for Olympus products offered through Olympus Financing, supporting healthcare provider equipment acquisition. Certified Pre-owned program provides refurbished equipment sales.
5. Reprocessing and Infection Prevention Products: Sale of infection prevention and reprocessing consumables including Acecide-C, ALDAHOL 1.8, and ALT-Pro, supporting cleaning, disinfection, and sterilization of reusable medical devices in healthcare settings.
6. Corporate Venture Investment Returns: Olympus Innovation Ventures Fund II commits $150 million to invest in early- to growth-stage MedTech startups in GI, Urology, and Respiratory, generating returns via M&A, partnerships, and equity appreciation.

Pricing tiers

Go-to-market motion5 records

Distribution channels8 records

Marketing channels8 records

Core offering

Olympus Corporation of the Americas manufactures and sells minimally invasive medical technology platforms—including endoscopy systems (EVIS X1), surgical imaging platforms (VISERA ELITE III, VISERA S OTV-S500), bipolar surgical energy devices (POWERSEAL), single-use bronchoscopes (H-SteriScope) and rhinolaryngoscopes (E-Steriscope), and specialty devices for gastroenterology, urology, pulmonology, ENT, and general surgery. The company supplements hardware with software (OLYSENSE, Olympus Knowledge Exchange), educational training (Olympus Continuum), service/repair, reprocessing consumables, and leasing/financing programs for healthcare providers across North and South America.

Product overview

Olympus Corporation of the Americas operates as a single integrated MedTech platform-plus-modules business under the "True to Life" philosophy, with a Medical Systems division spanning endoscopy, surgical imaging, surgical energy, and single-use devices, supported by training, service, reprocessing, and financing services. The portfolio centers on core endoscopy systems such as the EVIS X1 Endoscopy System (with GIF-1100 and CF-HQ1100DL/I endoscopes) and the OLYSENSE platform, paired with advanced surgical imaging platforms including the VISERA ELITE III and the VISERA S OTV-S500 (featuring 4K, 3D, and fluorescence-guided imaging) and the Olympus Systems Integration and Olympus Knowledge Exchange System (KE) for workflow management. Surgical energy is delivered through the POWERSEAL Sealer/Divider family (including the FDA-cleared Open Extended Jaw device and 5mm laparoscopic devices) and THUNDERBEAT tissue management, while single-use devices include the H-SteriScope bronchoscopes and E-Steriscope rhinolaryngoscopes, alongside specialty solutions such as the Olympus EBUS Solution, Hybrid Bronchoscopy Solution, ENDOEYE FLEX 3D, DIEGO ELITE Multidebrider, Spiration Valve System, and the iTind procedure. Patient-handling, reprocessing (Acecide-C, ALDAHOL 1.8, ALT-Pro), Certified Pre-owned equipment, Olympus Financial Services, and MyOlympus Service provide add-on modules around the core devices, with the Olympus Continuum educational platform and the Olympus Innovation Ventures Fund II ($150M MedTech venture fund) extending the offering into clinical training and external innovation.

Differentiator

Problem solved

Functional benefit

Brands

• Olympus Continuum™: Comprehensive platform of educational programs and training experiences designed to broaden clinical expertise and enhance procedural skills for healthcare professionals.
• Olympus Innovation Ventures

Products and services

• EVIS X1 Endoscopy System
• VISERA ELITE III Surgical Imaging Platform
• VISERA S OTV-S500 Endoscopic Imaging Platform
• POWERSEAL Sealer/Divider Family
• H-SteriScope Single-Use Bronchoscopes
• E-Steriscope Single-Use Rhinolaryngoscopes
• OLYSENSE Platform
• Aplio i800 EUS Premium Ultrasound System
• Olympus EBUS Solution
• Hybrid Bronchoscopy Solution
• iTind Procedure
• Spiration Valve System
• THUNDERBEAT
• ENDOEYE FLEX 3D
• DIEGO ELITE Multidebrider

Quantifiable outcome

• POWERSEAL portfolio expanded to 4 FDA-cleared devices (1 open jaw + 3 laparoscopic 5mm)
• +4 more outcomes

Segments8 records

Ideal customer profiles7 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature10 records

Partnerships

Nine partnerships are on record, tiered strategic, minor and flagship.

• First Nation GroupstrategicChannel Partner/ Reseller/ Distributor · 24 June 2026Olympus announced a Federal Healthcare Facility Distribution Agreement with First Nation Group on June 24, 2026. The partnership enables distribution of Olympus medical and surgical products to U.S. federal healthcare facilities, expanding reach into the federal procurement channel for VA and federal health systems.
• MedTech InnovatorminorGTM or Marketing Partner · 1 June 2026MedTech Innovator's 2026 Accelerator Cohort connects 65 selected startups (top 4% of 1,835 global applicants) with mentors, proprietary resources, and industry stakeholders including Olympus, culminating in competitions at The MedTech Conference in Boston and MedTech Strategist Innovation Summit in San Diego with $800,000 in funding.
• BioProtectstrategicStrategic or Co-development Partner · 26 May 2026Olympus announced acquisition of BioProtect on May 26, 2026 to expand its portfolio of urological technologies and address prostate cancer. BioProtect's BioProtect Balloon Spacer technology complements Olympus's urology offerings for prostate cancer treatment.
• EndoRoboticsstrategicChannel Partner/ Reseller/ Distributor · 4 May 2026Olympus signed a Global Distribution Agreement with EndoRobotics on May 4, 2026, adding robot-assisted technologies to Olympus's EndoTherapy portfolio. The partnership extends Olympus's robotics and AI integration roadmap and broadens its minimally invasive therapeutic device offering.
• CanonstrategicStrategic or Co-development Partner · 1 May 2026Olympus and Canon jointly introduced the Aplio i800 EUS Premium Ultrasound System in the U.S. on May 1, 2026. The collaboration brings Canon's ultrasound imaging capability to Olympus's endoscopic ultrasound (EUS) workflow, strengthening Olympus's diagnostic imaging portfolio for GI and adjacent specialties.
• Sony Olympus Medical Solutions (SOMED)flagshipStrategic or Co-development Partner · 11 March 2026VISERA ELITE III surgical imaging platform co-developed with Sony Olympus Medical (SOMED) and launched in the U.S. on March 11, 2026. The platform offers advanced imaging technologies including 4K, 3D, and fluorescence-guided surgery to support clinical decision-making and workflow efficiency across multiple surgical specialties.
• AdvaMed, MDMA, Health Innovation Alliance, American Hospital Association (AHA)minorGTM or Marketing Partner · 7 January 2026Olympus Corporation of the Americas joined AdvaMed, MDMA, Health Innovation Alliance, and AHA in submitting comments to the FDA urging the agency to use existing quality management system requirements rather than creating new regulatory frameworks for monitoring AI-enabled medical devices.
• OM Digital SolutionsminorOEM/ Whitelabel/ Licensing PartnerSince January 2021, Olympus's cameras, audio recorders, and binoculars have been transferred to and are being marketed, sold and distributed by OM Digital Solutions under a licensing arrangement. Customers are directed to explore.omsystem.com.
• Evident ScientificminorOEM/ Whitelabel/ Licensing PartnerLife Science Solutions and Industrial Solutions products are no longer owned or controlled by Olympus Corporation and are being marketed, sold and distributed by Evident. Referenced across multiple pages including homepage and contact page.

Scale indicators10 records

Recent moves9 records

Expansion highlights7 records

Direct peers

• Medtronic: Medtronic's GI, Surgical, and Respiratory operating units compete with Olympus across endoscopy, bronchoscopy (superDimension), and minimally invasive surgery. Both serve large hospital systems and compete in EBUS-guided diagnostics and pulmonary intervention.
• Conmed: Conmed competes directly with Olympus in surgical energy, smoke management, and ENT (through the In2Bones acquisition). Both target surgical specialties with energy devices and visualization tools across hospital and ASC settings.
• Boston Scientific: Boston Scientific's Endoscopy and Urology & Pelvic Health divisions directly compete with Olympus's EVIS X1, EndoTherapy, single-use bronchoscopes, and iTind offerings across GI, pulmonary, and urology specialties. Both companies target the same hospital and ASC customers with overlapping minimally invasive device portfolios.
• Stryker: Stryker's Endoscopy and Instruments divisions compete head-to-head with Olympus's surgical imaging (VISERA ELITE III), surgical energy (POWERSEAL), and visualization platforms. Both serve multi-specialty MIS markets and compete in 4K/3D surgical visualization and energy-based tissue management.
• Cook Medical: Cook Medical's Endoscopy and Urology divisions compete with Olympus in GI accessories (snares, ERCP), urological devices, and stone management. Both are privately held MedTech specialists with overlapping physician customer bases.
• Karl Storz: Karl Storz is a direct competitor in rigid and flexible endoscopy across ENT, urology, gynecology, and arthroscopy. Like Olympus, it is a multi-generational family-led endoscopy specialist with comparable visualization and instrumentation portfolios.

Emerging players

• Ambu: Ambu pioneered single-use endoscopes and is the most direct competitor to Olympus's H-SteriScope bronchoscopes and E-SteriScope rhinolaryngoscopes. Its single-use platform challenges Olympus's reusable installed base and pricing across pulmonary and ENT specialties.
• Hologic: Hologic competes in gynecological surgery and diagnostic imaging—adjacent to Olympus's gynecology/urology and women's health procedural offerings. Less direct overlap in core GI but increasingly relevant as ASC and office-based procedures expand.
• Intuitive Surgical: Intuitive's da Vinci platform and Ion robotic bronchoscopy overlap with Olympus's EndoTherapy/robot-assisted ambitions (EndoRobotics distribution) and with Olympus's EBUS/Hybrid Bronchoscopy Solution. Represents the robotic-surgery benchmark Olympus is targeting as it adds robot-assisted technologies.

Broad incumbents

• Johnson & Johnson (Ethicon): Johnson & Johnson MedTech's Ethicon division competes with Olympus's POWERSEAL and THUNDERBEAT surgical energy devices and with broader surgical visualization and instrumentation. J&J is a larger diversified incumbent with overlapping OR presence across surgical specialties.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/olympusamericas
• YouTubeyoutube.com/channel/UCVNs486f1499waYRbP8WdFA
• Facebookfacebook.com/OlympusCorpOfTheAmericas
• LinkedInlinkedin.com/company/olympus
• Instagraminstagram.com/olympusamericas

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments4 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Olympus Corporation of the Americas